Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Aptuit Drug Discovery & Development Center In Verona, Italy Hits 100th Client Milestone

GREENWICH, Connecticut, Nov. 8, 2012 /PRNewswire/ -- Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence from the marketplace.

(Logo:  http://photos.prnewswire.com/prnh/20120217/NY55633LOGO )

Mark Hembarsky, Vice President and Site Leader of the facility stated, "We are excited to have reached this important milestone of 100 clients at Aptuit Verona. In July of 2010, we started with one client, GlaxoSmithKline, following our acquisition of the site from them. Since that time, more and more clients have been recognizing that we have something unique and valuable to offer, and that we are certainly doing something right in helping them achieve their goals."

Mr. Hembarsky explained that in the two brief years since the acquisition, the Aptuit Verona facility has successfully made the transition from a single customer site to a dynamic drug discovery and development center attracting all types of clients – large, multinational pharmaceutical innovators, midsize and small pharma companies, biotechs and startups.

"Companies from the EU, North America, Asia and South America have placed projects with us covering numerous therapeutic areas," said Mr. Hembarsky. "We are proud that industry-leading companies like Pfizer Inc., Chiesi Farmaceutici, Sunovion Pharmaceuticals Inc., Boehringer Ingelheim, UCB, C10 Pharma, Autifony Therapeutics and GlaxoSmithKline are among the clients that have chosen to partner with Aptuit." He added that most clients have subsequently contracted repeat business with Aptuit and many have requested proposals for additional work before their initial project was completed.

"Our growth is a testimony to Aptuit's capabilities, and continued business inquiries are a source of great encouragement. Clients recognize that we offer the intelligence and insights of scientific professionals engaged in multidisciplinary activities, from integrated discovery, preclinical development, API and drug product development and clinical sciences through to clinical Proof of Concept.  Our 'heads for science' are accustomed to taking a big picture approach, applying what we call Integrated Knowledge. Because of our legacy as an R&D engine of a leading pharmaceutical company, we understand the total process of drug discovery and development and we apply that understanding to all work that we perform – whether it's fully integrated services or a specific stand-alone project. Our teams of highly experienced and knowledgeable drug development professionals can anticipate potential problems and offer preemptive solutions, allowing clients to mitigate risks, save time and reduce costs. Our 'hearts for service' are devoted to understanding what is important to each project and delivering, as promised, on time and in full, ultimately helping each client achieve their goals," said Mr. Hembarsky.

Mr. Needleman concluded, "We are very pleased that clients understand that they are getting the best of both worlds when they work with Aptuit Verona – the efficiency of an experienced CRO combined with the scientific expertise of a large pharmaceutical research and development engine. We're now at 100, and still counting."

Aptuit LLC provides the most complete set of integrated early to mid-phase development services in the pharmaceutical industry. Drug Design & Discovery, Preclinical Biosciences, API Development and Manufacture, Solid State Chemistry, Drug Product Formulation Development & Manufacture, Sterile Fill Finish, Clinical Sciences, Consulting and Aptuit INDiGOO (a program that accelerates drug development) are offered as stand alone or integrated services. Fully integrated drug discovery & development services are available from a single site at The Aptuit Center for Drug Discovery & Development in Verona, Italy. The company maintains five global facilities with approximately 800 employees in Europe and the United States, and has a strategic relationship with Laurus Labs in India. Aptuit LLC is partnered with Welsh, Carson, Anderson & Stowe, one of the world's leading private equity investors.

For more information about Aptuit, visit www.aptuit.com

CONTACT:  Maria Garvey, +1-1-914-747-1400, maria@delfino.com

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Every organization collects, stores and retains portions of dark data. It's the digital equivalent of emotional baggage which hangs around after every user interaction, transaction, and customer engagement. In fact, not using data effectively is costing United Airlines almost $1 Billio...
We’re starting to see predictions about what’s going to be hot in enterprise technology in 2017. Cloud (yet again), Blockchain, Big Data / Analytics, Internet of Things (IoT) are all among the top of the list. However, it was Krish Subrumanian’s humorous tweet that started me thinking...
Over the past few years, the use of artificial intelligence has expanded more rapidly than many of us could have imagined. While this may invoke fear and dread in some, these relatively new technology applications are clearly delivering real value to our global society. This value is ...
For those of us in IT management, analytics is a familiar topic with a familiar value proposition. But for many organizations, success with IT analytics is less familiar. Why do so many fail in their adoption attempts? And how can you avoid failure and embrace success? As we'll see bel...
As the network has moved from a physical entity to a more abstract one, IT has valiantly kept pace by researching and deploying new network devices and functionality. IT teams have had to shift workloads and mindsets to the cloud and to SaaS providers, while remaining responsible for e...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE